In 2022 alone, the Remote Patient Monitoring (RPM) market grew to over $50 billion with the market set to exceed $175 billion by the year 2027.1 In recent years, numerous medical studies have concluded better health outcomes and lower costs as a result of RPM programs.2 For providers and payers, treatment plans consisting of RPM for conditions such as diabetes, hypertension, congestive heart failure, and COPD have seen massive improvements in clinical outcomes while yielding cost-savings, and yet RPM had yet to be offered in GI…until now.
Today, Salvo Health announces the first-ever RPM offering for chronic GI conditions, including IBS, GERD/reflux, dyspepsia, Celiac, SIBO, and more. This new offering seeks to not only optimize better clinical outcomes for patients but increase practice reach and annual revenue for participating partners.